Dod Uniform Formulary Blanket Purchase Tender in USA - 12975249

Procurement Summary

Country: USA

Summary: Dod Uniform Formulary Blanket Purchase Agreement/Additional Discount Program

Deadline: 30 Jun 2017

Posting Date: 08 May 2017

Other Information

Notice Type: Tender

TOT Ref.No.: 12975249

Document Ref. No.: HT9402-17-Q-0006

Competition: ICB

Financier: Self Financed

Purchaser Ownership: -

Tender Value: Refer Document

CPV Classification

33600000 - Pharmaceutical products

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_details

Login to see details

Tender Details

Background: the department of defense (dod) is required by law (10 u.s.c. § 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the military health system (mhs) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 cfr section 199.21) describe the process by which the dod pharmacy and therapeutics (p&t) committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the dod uniform formulary (uf) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, basic core formulary (bcf), extended core formulary (ecf), or non-formulary (nf). Prior to the scheduled p&t committee meeting, a request for quotation (rfq) for pharmaceutical agents within drug classes identified for placement on the uf has been issued to obtain quotes from industry. The defense health agency may award uniform formulary blanket purchase agreements (uf bpa) and the uniform formulary additional discount program agreements (uf adp) based on the uf decision. This process is described in the attached rfq.
P&t committee meeting: august 2017. The following drug classes/subclass and agents will be reviewed:
antiretrovirals sub-class: other agents
aptivus, crixivan, edurant, evotaz, intelence, invirase, kaletra, lexiva, norvir, prezcobix, prezista, rescriptor, selzentry, tybost, viracept
antiretrovirals sub-class: combinations
atripla, complera, genvoya, odefsey, stribild, triumeq
antiretrovirals sub-class: instis
isentress, tivicay, vitekta
antiretrovirals sub-class: nrtis
descovy, emtriva, trizivir, truvada, viread, ziagen
corticosteroid sub-class: hae
berinert, cinryze, firazyr, kalbitor, ruconest
insulins sub-class: basal
basaglar kwikpen u-100, lantus, lantus solostar, levemir, levemir flexpen, levemir flextouch, toujeo solostar, tre...

Documents

 Tender Notice